Background: Sub-Saharan Africa is currently experiencing a high burden of both
INTRODUCTION
The incidence, prevalence and mortality secondary to stroke in Low-and-Middle Income Countries (LMICs) in sub-Saharan Africa (SSA) have rapidly risen in recent decades.
1-14 These recent secular trends contrasts sharply with the scenario in HighIncome Countries (HICs) where burden of stroke is receding due to improved control
A C C E P T E D M A N U S C R I P T
of vascular risk factors. [15] [16] [17] Stroke among Africans has a predilection to be hemorrhagic 18 , affect a younger population 19 and is associated with a myriad of poststroke comorbidities including persisting functional limitations 20 , depression 21, 22 , cognitive impairment 23, 24 , and stigma 25 in the setting with limited access to neurologists and rehabilitation services. Because stroke care is severely challenged in LMICs, the most sustainable long-term approach to mitigating the enormous burden imposed by stroke in LMICs is to identify and characterize the risk factors associated with stroke occurrence for primary prevention at the population level.
The association between chronic kidney disease (CKD) and stroke occurrence among
Africans although some studies have demonstrated the existence of such associations in other populations. [29] [30] [31] [32] [33] [34] [35] Pathophysiologically, both the brain and kidneys are susceptible to vasculature injuries due to reliance on similar microvasculature that allows for continuous high volume perfusion. In addition, stroke and renal disease commonly share traditional vascular risk factors such as hypertension, diabetes, obesity, dyslipidemia and obesity. There are suggestions from the literature of regional and racial differences on the effect of CKD on incident stroke, with a greater burden among Asians.
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There are no published studies among indigenous Africans that have specifically assessed the association between CKD and stroke. The highest frequencies of renal related variants of apolipoprotein L1 (APOL1)-associated with non-diabetic kidney disease are reported among West Africans 37, 38 . Given the recently reported association between APOL-1 variants and small vessel disease strokes among West Africans 39 , there is justifiable scientific incentive to investigate the associations between CKD and stroke risk among indigenous Africans further. We therefore sought to narrow the existing knowledge gaps by exploring prospectively the association between chronic kidney disease and stroke incidence among Ghanaians with hypertension and/or diabetes mellitus. Participants were recruited as part of a pragmatic clinical trial aimed at improving access to medicines for the control of hypertension and diabetes by offering medications at differential pricing. A C C E P T E D M A N U S C R I P T which has been validated locally. [42] [43] [44] QVSFS was used as neuro-imaging facilities
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METHODS
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were not available at any of the study sites at the time of the study. Study participants visited every 2 months for 18 months to assess control of hypertension and diabetes mellitus and to assess for vascular complications including stroke. Stroke diagnosis was adjudicated by FSS, (a neurologist). Prevalent stroke was defined as stroke diagnosis at time of enrollment into the study while incident stroke was defined as stroke diagnosed during follow-up of study participants. Incident stroke was identified prospectively among participants without stroke at baseline.
Renal impairme nt:
Renal impairment was defined using estimated glomerular filtration rate (eGFR) calculated from baseline serum creatinine measurement using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula.
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Physical Activity
Individuals were classified as physically active if they were regularly involved in moderate exercise (walking, cycling, or gardening) or strenuous exercise (jogging, football, and vigorous swimming) for 4 hours or more per week.
Alcohol Use
Alcohol use was categorized into current users (users of any form of alcoholic drinks) or never/former drinker while alcohol intake was categorized as low drinkers (1-2 drinks per day for female and 1-3 drinks per day for male) and high drinker (>2 drinks per day for female and >3 drinks per day for male. 1 drink or 1 unit of alcohol = 8g of alcohol).
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Smoking Status
Smoking status was defined as current smoker (individuals who smoked any tobacco in the past 12 months) or never or former smoker. 46 Ve getable and fruit intake was assessed based on number of daily servings per week.
Statistical analysis:
Baseline characteristics of patients with hypertension, diabetes and dual diagnosis of diabetes and hypertension were compared using Analysis of variance for 3-group comparisons or by using the Student's t-test for 2-group comparisons. Proportions were compared using the Chi-squared tests or Fisher's exact test for proportions with subgroupings <5. At baseline, factors associated with prevalent stroke were assessed using a logistic regression model. Crude incidence 
DISCUSSION
In this prospective hospital based cohort of Ghanaians with hypertension and diabetes mellitus, we found CKD assessed using estimated glomerular filtration rate to be independently associated with stroke occurrence. At baseline, we observed a high frequency of renal impairment among the cohort with approximately 15% having
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eGFR <60ml/min. Incident stroke risk increased with declining renal function among a clinically stroke-free cohort at enrollment who were followed up prospectively.
Overall, stroke risk increased by 42% among participants with eGFR of 60 to 89 ml/min, by 88% among those with eGFR between 30 to 59 ml/min and by 52% among those with eGFR<30ml/min compared with participants with normal eGFR.
Among patients with hypertension, an eGFR<60ml/min was significantly associated with an adjusted HR of 3.69 (95%CI: 1.49-9.31) for stroke occurrence while that among diabetic patients did not reach statistical significance. This to the best of our knowledge is the first study in sub-Saharan Africa to prospectively assess the predictive associations between renal dysfunction and stroke risk among individuals on treatment for hypertension and/or diabetes.
A meta-analysis performed nearly a decade ago involving a prospective cohort of 285,000 participants from 33 studies (followed up for 3.2 to 15 years) with 7,900 strokes demonstrated a 43% increased risk for stroke occurrence for eGFR <60ml/min compared with those with normal baseline eGFR. 33 In that seminal meta-analysis, general or hypertensive patients with eGFR <60ml/min had a 58% increased risk of stroke compared with those with normal baseline eGFR and Asians had higher risk of stroke from CKD than non-Asians but no African cohorts were included in that study. 33 In the present study, Ghanaian hypertensive patients with eGFR<60ml/min had a 269% higher risk of stroke, p=0.0047 but no significant association were observed among diabetics. The toxic bidirectional relationship between CKD and cerebrovascular diseases, known as cerebro-renal interaction has gathered scientific momentum over the past decade. CKD is independently associated with both ischemic and hemorrhagic stroke types 29-35 as well as with recurrent strokes
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. CKD is associated with cerebral microbleeds, which are clinically silent, discrete punctate hypodense lesions 5-10 mm in size evidenced on gradient-recall echo (GRE) T2*-weighted MRI. 47 Cerebral microbleeds are important harbingers of intracerebral hemorrhage 48, 49 which are commoner among indigenous Africans and African
Americans than European Americans. 50, 51 Interestingly, declining renal function is closely associated with a surge in vascular inflammation, oxidative stress and anemia which may potentiate the occurrence of cardiovascular events via generalized endothelial dysfunction and systematic vascular remodeling. 52, 53 The salience of renal impairment and increased stroke risk particularly among individuals of African
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ancestry may have strong genetic underpinnings based on more recent evidence.
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The SIREN investigators involved in the largest study on stroke in Africa to date,
were the first to demonstrate an association between APOL1 variant rs73885319 and 
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ACEI or ARBs among participants in the present study were unknown. A systematic review of ischemic stroke survivors on either ACE inhibitors or ARBs showed a modest reduction in risk for recurrent strokes 62 as a secondary prevention strategy, thus a larger sample size may be required to show benefit or otherwise of ACE-I and ARBs in primary prevention of stroke in SSA. Importantly, as the weight of evidence supporting the plausibility of CKD as a risk factor for stroke and indeed other CVDs becomes substantial, the question of whether eGFR is simply a risk marker or is etiologically linked to stroke occurrence will require further interrogation. For instance, among Ghanaians in the present cohort, eGFR was independently associated with poor glycemic 63 and blood pressure control 64 , and poor BP control is potently associated with stroke occurrence. 65 However, an interesting nationwide cohort in
Taiwan found evidence to suggest that CKD is a causal risk factor for stroke beyond traditional cardiovascular risk factors. 66 The prospective design of our study is an important strength because it minimizes confounding from recall bias, selection bias and reverse causality associations.
Furthermore, participants of the study were recruited from hospitals at primary, secondary and tertiary cadres of healthcare distributed across Gha na, which enhances the generalizability of our study findings. However, the lack of confirmation of stroke with neuro-imaging, which is considered as the gold standard is a limitation worth noting. We relied on clinical assessments by study physicians to co nfirm stroke diagnosis which may be subject to diagnostic misclassification. Unavailability of CT scans at most of the study sites precluded us from radiologic confirmation of clinically suspected strokes. There is a possibility that we missed some severe or fatal stroke cases who did not report to clinic for follow-up since strokes were assessed only among participants who reported for follow-up visits. However, when participants missed clinic visits we followed up with telephone calls to ascertain reasons for default. Well known vascular risk factors such as atrial fibrillation and dyslipidemia were not systematically assessed because electrocardiography were not undertaken for all participants and only a fourth of study population was supported by the study to cover lipid panel costs. In spite of these limitations, we believe our study contributes to literature by providing evidence from West Africa to strengthen the reported associations between chronic kidney disease and stroke occurrence on the
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A C C E P T E D M A N U S C R I P T globe. More cohort studies of such nature are needed to assess the impact of renal disease on strokes occurrence in low-and-middle income countries in SSA.
In conclusion, chronic kidney disease is dose-dependently associated with occurrence of incident strokes among Ghanaians with hyperte nsion and diabetes mellitus. Further studies are required to explore interventions that could attenuate the risk of stroke attributable to renal disease among patients with hypertension in SSA.
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The Funders were kept apprised of progress in developing and implementing the study program in Ghana but had no role in study design, data collection, data analysis or in study report writing. 
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A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T ACE-I = Angiotensin-converting enzyme inhibitor; ARB = Angiotensin Receptor Blocker, eGFR = estimated glomerular filtration rate derived using the CKD-EPI formula from serum creatinine measurement (data available for 2631 participants)
A C C E P T E D M A N U S C R I P T 
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T Highlights  We assessed association between incident stroke and estimated glomerular filtration rate  2631 participants stroke-free Ghanaian adults with hypertension or diabetes were followed for 14 months  There were 45 incident strokes  Incident stroke risk independently increased with declining eGFR
